An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and…

Overview of attention for article published in BMC Health Services Research, July 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the… https://t.co/f1m986Dl0G #prosta

15 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.